Core videos and podcasts
- Endocrine Society — ENP107 episode and sponsorship disclosure
- Endocrine Society — ENP107 YouTube video
- Frier Levitt — FDA and state-board perspectives, YouTube
- Frier Levitt — webinar-series dates and descriptions
- JAMA — July 10, 2026 episode and transcript
- ASHP — New Agents, New Data, and New Access Opportunities
- IPC — Manufacturer Direct D2C episode and transcript
- PharmaSource — Ryan Kelly interview recap
- PharmaSource — podcast audio listing and duration
- Judi Health — AH104 episode and chapters
Specialist recordings and handouts
- NABP — GLP-1 compounding safety home study
- NABP — telemedicine compliance home study
- NABP — telemedicine presentation handout
- NABP — illicit and counterfeit GLP-1 medicines home study
- NABP — counterfeit-medicines presentation handout
Regulatory and access checks
Sources cited on this page
- endocrine.org · Source 1 ↗https://www.endocrine.org/podcast/enp107
- youtube.com · Source 2 ↗https://www.youtube.com/watch?v=9YZFfBj_Ybk
- youtube.com · Source 3 ↗https://www.youtube.com/watch?v=a0edKHk28lU
- frierlevitt.com · Source 4 ↗https://www.frierlevitt.com/webinars/navigating-glp-1-compounding-2-part-webinar-series/
- edhub.ama-assn.org · Source 5 ↗https://edhub.ama-assn.org/jn-learning/audio-player/19077724
- ashp.org · Source 6 ↗https://www.ashp.org/professional-development/ashp-podcasts/clinical-conversations/2026/glp-practice-insights-new-agents-new-data-and-new-access-opportunities
- ipcrx.com · Source 7 ↗https://www.ipcrx.com/pharmacy-podcasts/manufacturer-direct-d2c-and-the-future-of-independent-pharmacy/
- pharmasource.global · Source 8 ↗https://pharmasource.global/content/podcast/why-pharmas-direct-to-consumer-shift-is-moving-faster-than-infrastructure-can-handle/
- podcasts.apple.com · Source 9 ↗https://podcasts.apple.com/ie/podcast/the-pharma-direct-to-consumer-shift-moving-faster/id1676259280?i=1000759494894
- judi.health · Source 10 ↗https://www.judi.health/insights/ah104---biosimilars-glp-1s-pbm-reform-and-other-2026-pharmacy-drivers-with-bridget-mulvenna
- nabp.pharmacy · Source 11 ↗https://nabp.pharmacy/resource/a-new-regulatory-path-for-enforcing-glp-1-compounding-safety-home-study/
- nabp.pharmacy · Source 12 ↗https://nabp.pharmacy/resource/navigating-the-regulatory-maze-telemedicine-compliance-and-its-impact-on-pharmacies-and-the-public-health-home-study/
- nabp.pharmacy · Source 13 ↗https://nabp.pharmacy/wp-content/uploads/2025/02/Telehealth-Webinar-Handout-February-13-2025_2.pdf
- nabp.pharmacy · Source 14 ↗https://nabp.pharmacy/resource/illicit-and-counterfeit-drugs-threaten-americans-in-the-glp-1-space-home-study/
- nabp.pharmacy · Source 15 ↗https://nabp.pharmacy/wp-content/uploads/2025/08/Illicit-and-Counterfeit-Drugs-Threaten-Americans-in-the-GLP-1-Space-Presentation-Handouts.pdf
- fda.gov · Source 16 ↗https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
- fda.gov · Source 17 ↗https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026
- fda.gov · Source 18 ↗https://www.fda.gov/drugs/human-drug-compounding/fda-telehealth-companies-what-know-when-promoting-compounded-drugs
- pharmacy.ohio.gov · Source 19 ↗https://www.pharmacy.ohio.gov/documents/pubs/special/compounding/compounding%20of%20glp-1%20drug%20products%20in%20ohio.pdf
- lilly.com · Source 20 ↗https://www.lilly.com/lillydirect/faq
- novocare.com · Source 21 ↗https://www.novocare.com/hcp/delivery.html